MyD88 Signaling in the CNS Is Required for Development of Fatty Acid-Induced Leptin Resistance and Diet-Induced Obesity

Cell Metabolism

Volumn 10, Issue 4, 2009, Pages 249-259

  Kleinridders, André ^a,b,c   Schenten, Dominik ^d   Könner, A Christine ^a,b,c   Belgardt, Bengt F ^a,b,c   Mauer, Jan ^a,b,c   Okamura, Tomoo ^a,b,c   Wunderlich, F Thomas ^a,b,c   Medzhitov, Ruslan ^d   Brüning, Jens C ^a,b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HUMDISEASE; MOLNEURO

Indexed keywords

GLUCOSE; LEPTIN; MYELOID DIFFERENTIATION FACTOR 88; PALMITIC ACID; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; FEMALE; GENE DELETION; GLUCOSE METABOLISM; HORMONE RESISTANCE; IN VIVO STUDY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; DIET; DIETARY FATS; EATING; ENERGY METABOLISM; ENZYME ACTIVATION; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; I-KAPPA B KINASE; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MYELOID DIFFERENTIATION FACTOR 88; OBESITY; PALMITIC ACID; SIGNAL TRANSDUCTION; WEIGHT GAIN;

MUS;

EID: 70349484212     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.08.013     Document Type: Article

References (59)

1. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
2. Alfadda A., DosSantos R.A., Stepanyan Z., Marrif H., and Silva J.E. Mice with deletion of the mitochondrial glycerol-3-phosphate dehydrogenase gene exhibit a thrifty phenotype: effect of gender. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R147-R156
3. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005) 191-198
4. Belgardt B.F., Husch A., Rother E., Ernst M.B., Wunderlich F.T., Hampel B., Klockener T., Alessi D., Kloppenburg P., and Bruning J.C. PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metab. 7 (2008) 291-301
5. Bence K.K., Delibegovic M., Xue B., Gorgun C.Z., Hotamisligil G.S., Neel B.G., and Kahn B.B. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 12 (2006) 917-924
6. Bjorbaek C., El-Haschimi K., Frantz J.D., and Flier J.S. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274 (1999) 30059-30065
7. Born J., Lange T., Kern W., McGregor G.P., Bickel U., and Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5 (2002) 514-516
8. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wieland D., and Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
9. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., and Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11 (2005) 183-190
10. Caricilli A.M., Nascimento P.H., Pauli J.R., Tsukumo D.M., Velloso L.A., Carvalheira J.B., and Saad M.J. Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J. Endocrinol. 199 (2008) 399-406
11. Chibalin A.V., Leng Y., Vieira E., Krook A., Bjornholm M., Long Y.C., Kotova O., Zhong Z., Sakane F., Steiler T., et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132 (2008) 375-386
12. Davis J.E., Gabler N.K., Walker-Daniels J., and Spurlock M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16 (2008) 1248-1255
13. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., Boschero A.C., Saad M.J., and Velloso L.A. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146 (2005) 4192-4199
14. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388 (1997) 548-554
15. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., and Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105 (2000) 1827-1832
16. Frederich R.C., Hamann A., Anderson S., Lollmann B., Lowell B.B., and Flier J.S. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1 (1995) 1311-1314
17. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
18. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
19. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997) 131-141
20. Janssens S., and Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 27 (2002) 474-482
21. Kawai T., and Akira S. TLR signaling. Cell Death Differ. 13 (2006) 816-825
22. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122
23. Kievit P., Howard J.K., Badman M.K., Balthasar N., Coppari R., Mori H., Lee C.E., Elmquist J.K., Yoshimura A., and Flier J.S. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab. 4 (2006) 123-132
24. Kim F., Pham M., Luttrell I., Bannerman D.D., Tupper J., Thaler J., Hawn T.R., Raines E.W., and Schwartz M.W. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100 (2007) 1589-1596
25. Koch L., Wunderlich F.T., Seibler J., Konner A.C., Hampel B., Irlenbusch S., Brabant G., Kahn C.R., Schwenk F., and Bruning J.C. Central insulin action regulates peripheral glucose and fat metabolism in mice. J. Clin. Invest. 118 (2008) 2132-2147
26. Konner A.C., Janoschek R., Plum L., Jordan S.D., Rother E., Ma X., Xu C., Enriori P., Hampel B., Barsh G.S., et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 5 (2007) 438-449
27. Lee J.Y., Sohn K.H., Rhee S.H., and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276 (2001) 16683-16689
28. Lewitt M.S., and Brismar K. Gender difference in the leptin response to feeding in peroxisome-proliferator-activated receptor-alpha knockout mice. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 1296-1300
29. Lim C.P., and Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK. J. Biol. Chem. 274 (1999) 31055-31061
30. Listenberger L.L., Ory D.S., and Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 276 (2001) 14890-14895
31. Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., and Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proc. Natl. Acad. Sci. USA 96 (1999) 7047-7052
32. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., Tsukumo D.M., Anhe G., Amaral M.E., Takahashi H.K., et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 29 (2009) 359-370
33. Mistry A.M., Swick A.G., and Romsos D.R. Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice. J. Nutr. 127 (1997) 2065-2072
34. Mori H., Hanada R., Hanada T., Aki D., Mashima R., Nishinakamura H., Torisu T., Chien K.R., Yasukawa H., and Yoshimura A. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10 (2004) 739-743
35. Obici S., Zhang B.B., Karkanias G., and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8 (2002) 1376-1382
36. Ozcan L., Ergin A.S., Lu A., Chung J., Sarkar S., Nie D., Myers Jr. M.G., and Ozcan U. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9 (2009) 35-51
37. Plum L., Schubert M., and Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16 (2005) 59-65
38. Plum L., Belgardt B.F., and Bruning J.C. Central insulin action in energy and glucose homeostasis. J. Clin. Invest. 116 (2006) 1761-1766
39. Plum L., Ma X., Hampel B., Balthasar N., Coppari R., Munzberg H., Shanabrough M., Burdakov D., Rother E., Janoschek R., et al. Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J. Clin. Invest. 116 (2006) 1886-1901
40. Poggi M., Bastelica D., Gual P., Iglesias M.A., Gremeaux T., Knauf C., Peiretti F., Verdier M., Juhan-Vague I., Tanti J.F., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50 (2007) 1267-1276
41. Posey K.A., Clegg D.J., Printz R.L., Byun J., Morton G.J., Vivekanandan-Giri A., Pennathur S., Baskin D.G., Heinecke J.W., Woods S.C., et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 296 (2009) E1003-E1012
42. Rohl M., Pasparakis M., Baudler S., Baumgartl J., Gautam D., Huth M., De Lorenzi R., Krone W., Rajewsky K., and Bruning J.C. Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. J. Clin. Invest. 113 (2004) 474-481
43. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Kustermann E., et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 101 (2004) 3100-3105
44. Schwartz M.W., and Porte Jr. D. Diabetes, obesity, and the brain. Science 307 (2005) 375-379
45. Schwartz M.W., Woods S.C., Porte Jr. D., Seeley R.J., and Baskin D.G. Central nervous system control of food intake. Nature 404 (2000) 661-671
46. Senn J.J. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 281 (2006) 26865-26875
47. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., and Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006) 3015-3025
48. Shoelson S.E., Lee J., and Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord. 27 Suppl 3 (2003) S49-S52
49. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., Prada P.O., Hirabara S.M., Schenka A.A., Araujo E.P., Vassallo J., Curi R., Velloso L.A., and Saad M.J. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56 (2007) 1986-1998
50. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
51. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
52. Wisse B.E., Ogimoto K., Morton G.J., Williams D.L., and Schwartz M.W. Central interleukin-1 (IL1) signaling is required for pharmacological, but not physiological, effects of leptin on energy balance. Brain Res. 1144 (2007) 101-106
53. Won J.C., Jang P.G., Namkoong C., Koh E.H., Kim S.K., Park J.Y., Lee K.U., and Kim M.S. Central administration of an endoplasmic reticulum stress inducer inhibits the anorexigenic effects of leptin and insulin. Obesity (Silver Spring) (2009) 10.1038/oby.2009.194 in press. Published online June 18 2009
54. Woods S.C., Lotter E.C., McKay L.D., and Porte Jr. D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282 (1979) 503-505
55. Wunderlich F.T., Luedde T., Singer S., Schmidt-Supprian M., Baumgartl J., Schirmacher P., Pasparakis M., and Bruning J.C. Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proc. Natl. Acad. Sci. USA 105 (2008) 1297-1302
56. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
57. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
58. Yaswen L., Diehl N., Brennan M.B., and Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5 (1999) 1066-1070
59. Zhang X., Zhang G., Zhang H., Karin M., Bai H., and Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135 (2008) 61-73